EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Inhibiting G6PD by quercetin promotes degradation of EGFR T790M mutation

Zehe Ge, Miao Xu, Yuqian Ge, Guang Huang, Dongyin Chen, Xiuquan Ye, Yibei Xiao, Hongyu Zhu, Rong Yin, Hua Shen, Gaoxiang Ma, Lianwen Qi und 9 weitere

Cell Reports · 2023-11 · 42 (11) · 113417

DOI: 10.1016/j.celrep.2023.113417 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2023-11. Verfasst von Zehe Ge und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Food Hygiene, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China; Jiang…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

EGFRT790M mutation causes resistance to the first-generation tyrosine kinase inhibitors (TKIs) in patients with non-small cell lung cancer (NSCLC). However, the therapeutic options for sensitizing first TKIs and delaying the emergence of EGFRT790M mutant are limited. In this study, we show that quercetin directly binds with glucose-6-phosphate dehydrogenase (G6PD) and inhibits its enzymatic activity through competitively abrogating NADP+ binding in the catalytic domain. This inhibition subsequently reduces intracellular NADPH levels, resulting in insufficient substrate for methionine reductase A (MsrA) to reduce M790 oxidization of EGFRT790M and inducing the degradation of EGFRT790M. Quercetin synergistically enhances the therapeutic effect of gefitinib on EGFRT790M-harboring NSCLCs and delays the acquisition of the EGFRT790M mutation. Notably, high levels of G6PD expression are correlated with poor prognosis and the emerging time of EGFRT790M mutation in patients with NSCLC. These findings highlight the potential implication of quercetin in overcoming EGFRT790M-driven TKI resistance by directly targeting G6PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsHumansErbB ReceptorsQuercetinProtein Kinase InhibitorsGlucosephosphate DehydrogenaseMutationDrug Resistance, Neoplasm

Stichwörter der Autor:innen

CP: CancerEGFR(T790M)G6PDMsrAgefitinibglucose-6-phosphate dehydrogenasemethionine oxidizationmethionine reductase Aquercetin

Substanzen

ErbB ReceptorsQuercetinProtein Kinase InhibitorsGlucosephosphate DehydrogenaseEGFR protein, human

Autor:innen und Institutionen

  • Department of Nutrition and Food Hygiene, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborati…
  • Department of Health Inspection and Quarantine, School of Public Health, Nanjing Medical University, Nanjing 211166, China.
  • Department of Medicinal Chemistry, School of Pharmacy, Nanjing Medical University, Nanjing 211166, China.
  • State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China; Department of Pharmacology, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China.
  • Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Nanjing Medical University Affiliated Cancer Hospital and Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing 21009, China.
  • Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China; Department of Oncology, Sir Run Run Hospital, Nanjing Medical University, Nanjing 211166, China.

Förderung

  • Natural Science Foundation of Jiangsu Province
  • National Natural Science Foundation of China

Zitieren

APA

Ge, Z., Xu, M., Ge, Y., Huang, G., Chen, D., Ye, X., Xiao, Y., Zhu, H., Yin, R., Shen, H., Ma, G., Qi, L., Wei, G., Li, D., Wei, S., Zhu, M., Ma, H., Shi, Z., Wang, X., …, & Qian, X. (2023). Inhibiting G6PD by quercetin promotes degradation of EGFR T790M mutation. Cell Reports, 42(11), 113417. https://doi.org/10.1016/j.celrep.2023.113417

Vancouver

Ge Z, Xu M, Ge Y, Huang G, Chen D, Ye X, et al. Inhibiting G6PD by quercetin promotes degradation of EGFR T790M mutation. Cell Reports. 2023;42(11):113417. doi:10.1016/j.celrep.2023.113417

BibTeX
@article{Ge2023,
  author = {Ge, Zehe and Xu, Miao and Ge, Yuqian and Huang, Guang and Chen, Dongyin and Ye, Xiuquan and Xiao, Yibei and Zhu, Hongyu and Yin, Rong and Shen, Hua and Ma, Gaoxiang and Qi, Lianwen and Wei, Guining and Li, Dongmei and Wei, Shaofeng and Zhu, Meng and Ma, Hongxia and Shi, Zhumei and Wang, Xiuxing and Ge, Xin and Qian, Xu},
  title = {Inhibiting G6PD by quercetin promotes degradation of EGFR T790M mutation},
  journal = {Cell Reports},
  year = {2023},
  volume = {42},
  number = {11},
  pages = {113417},
  doi = {10.1016/j.celrep.2023.113417}
}
Kostenlos starten →